Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amine Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101723891A details a novel route for diarylamines using N-aryl carbamates, offering high purity and yield for p38 kinase inhibitors.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN1759097A details a safer process for PDF inhibitor intermediates using specific beta-lactams and selective debenzylation, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel iodine-catalyzed oxidative sulfonylation method for high-purity pharmaceutical intermediates with reduced costs and scalable production capabilities.
Novel oleum-based process for thioalkylamines eliminates evaporation steps. High space-time yield and scalable route for pharmaceutical intermediates manufacturing.
Patent CN102477000A details a streamlined 5-step synthesis for beta-2 agonists, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN105622304B offers derivatization method reducing genotoxic impurities below 2ppm ensuring supply chain reliability and cost efficiency.
Patent CN105873897A reveals mild catalytic hydrogenation for amines. Achieve cost reduction in amine manufacturing and high-purity pharmaceutical intermediates.
Patent CN102086143A details gold-catalyzed nitro reduction. Offers high purity, mild conditions, and supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN1296472A reveals a method suppressing by-products for high-yield diamine synthesis, offering cost-effective supply chain solutions.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Patent CN1729174B details a robust route to oxindole and indole derivatives, bypassing hazardous hydrazine steps for reliable API intermediate supply.
Patent CN105873897B reveals mild amine synthesis. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Patent CN101429230B reveals resin-based purification achieving over 99% purity. This method reduces impurities for injectable applications and offers significant supply chain cost advantages.
Patent CN105658627B enables selective monoarylation for OLED intermediates. Discover cost reduction in electronic chemical manufacturing and high-purity supply solutions.
Patent CN118771989A reveals a novel manganese catalyst for amide reduction. This technology offers cost-effective, scalable solutions for high-purity pharmaceutical intermediate manufacturing.
Patent CN113789527B reveals a metal-free electrochemical route for aromatic amines, offering green synthesis and cost reduction for pharmaceutical intermediates manufacturing.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.